PLANA与NAM术前唇鼻牙槽突矫治的早期对比分析
本研究回顾性比较PLANA与NAM两种术前矫治技术在非综合征性唇腭裂患者中的效果,纳入50例(NAM 28例、PLANA 22例),并分析其中25例单侧完全性唇腭裂患者的鼻唇人体测量学比例变化。结果显示PLANA可显著降低就诊次数和短暂可逆性副作用,在鼻小柱长度比例改善上优于NAM,而NAM在鼻孔高度比例改善上更优;两组在鼻孔宽度、鼻翼基底宽度比例及鼻小柱偏斜角上无显著差异。
要点
- PLANA组总就诊次数较NAM组减少61.2%(5.2次 vs 13.4次,P<0.001)。
- PLANA组短暂可逆性副作用减少72.19%(18.18% vs 65.38%,P<0.001)。
- PLANA在鼻小柱长度比例改善上优于NAM(0.53 vs 0.37,P=0.026),NAM在鼻孔高度比例改善上更优(0.29 vs 0.39,P=0.04)。
核心结论
- PLANA可显著降低唇腭裂患者的治疗负担,并可能提供与NAM相当的鼻唇结局。
研究设计与样本
- 回顾性研究,纳入50例非综合征性单侧或双侧唇腭裂患者,NAM组28例(含2例中止治疗),PLANA组22例;其中25例单侧完全性唇腭裂患者(PLANA 12例,NAM 13例)进一步分析鼻唇人体测量学比例变化。
主要发现
- PLANA组总就诊次数较NAM组减少61.2%(5.2次 vs 13.4次,P<0.001)。
- PLANA组短暂可逆性副作用(口腔、鼻腔及面颊刺激)减少72.19%(18.18% [n=4] vs 65.38% [n=17],P<0.001)。
- PLANA组鼻小柱长度比例改善显著优于NAM组(0.53 vs 0.37,P=0.026)。
- NAM组鼻孔高度比例增加显著大于PLANA组(0.29 vs 0.39,P=0.04)。
- 两组在鼻孔宽度比例、鼻翼基底宽度比例及鼻小柱偏斜角上无显著差异。
临床怎么用
- 对于希望减少就诊次数和副作用负担的唇腭裂患者,PLANA可作为NAM的替代术前矫治选择。
- 选择矫治方案时需权衡鼻小柱长度与鼻孔高度改善的侧重,PLANA更利于鼻小柱长度,NAM更利于鼻孔高度。
局限性
- 回顾性研究设计,样本量有限(总样本50例,影像分析亚组25例)。
- 仅评估短期结局,缺乏长期随访数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study evaluates the presurgical lip, alveolus, and nose approximation (PLANA) technique as a novel alternative to nasoalveolar molding (NAM). The study hypothesizes that PLANA can achieve comparable nasolabial outcomes to NAM while addressing its limitations, particularly by reducing the burden of care. METHODS: A retrospective review was conducted on 50 patients with nonsyndromic unilateral or bilateral cleft lip and palate (CLP) treated with either NAM ( n = 28, including 2 treatment discontinuations) or PLANA ( n = 22). The overall physical burden of care was assessed in the full cohort. A subset of 25 patients with complete unilateral cleft lip and palate (PLANA, n = 12; NAM, n = 13) was further analyzed to assess changes in nasolabial anthropometric ratios between the cleft and noncleft side using standardized two-dimensional photographs taken before and after treatment. RESULTS: The physical burden of care was significantly lower in the PLANA group, with 61.2% fewer total office visits (5.2 versus 13.4; P < 0.001). The PLANA group also showed a 72.19% reduction in transient reversible side effects, such as oral, nasal, and cheek irritations (18.18% [ n = 4] versus 65.38% [ n = 17]; P < 0.001). PLANA achieved a significantly greater improvement in the columellar length ratio (0.53 versus 0.37; P = 0.026), whereas NAM demonstrated a greater increase in the nostril height ratio (0.29 versus 0.39; P = 0.04). No significant differences were observed in nostril width and alar base width ratios, or columellar deviation angle between the groups. CONCLUSION: These findings suggest that PLANA significantly reduces the burden of care for patients with cleft lip and palate and may offer comparable nasolabial outcomes to NAM.
引用
- Multani N, Plana NM, Staffenberg DA, et al. An Early Comparative Analysis of Presurgical Lip, Alveolus, and Nose Approximation and Nasoalveolar Molding. Plast Reconstr Surg. 2025. PMID: 40794405. doi:10.1097/PRS.0000000000012359
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。